InflaRx competitors

InflaRx's competitors include Tarveda Therapeutics, CorMedix, Pentec Health and Alexion Pharmaceuticals
Add company...
InflaRx
InflaRx develops new therapeutics in the field of acute and chronic inflammation.
Tarveda Therapeutics
Tarveda Therapeutics takes a novel approach to cancer treatment.
CorMedix
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
Pentec Health
Pentec Health is a privately held specialty infusion services and healthcare technology company.
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Founding Date
Founding Date
2006
Founding Date
2011
Founding Date
2006
Founding Date
1983
Founding Date
1992
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Jena, DE HQ
Planegg, DE
Locations
Watertown, US HQ
Locations
Bedminster Township, US HQ
Locations
Glen Mills, US HQ
Boothwyn, US
Mansfield, US
Boothwyn, US
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Toronto, CA
see more
Employees
Employees
9
Employees
333% increase
Employees
1456% increase
Employees
364
Employees
2,52519% decrease
Valuation ($)
Valuation ($)
787.3 m
Valuation ($)
N/A
Valuation ($)
19.3 m
Valuation ($)
N/A
Valuation ($)
28.4 b
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
620
Twitter followers
N/A
Twitter followers
1.8 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$329.3k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$3.1b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$115k (FY, 2017)
Cost of goods
N/A
Cost of goods
$258m (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$214.4k (FY, 2017)
Gross profit
N/A
Gross profit
$2.8b (FY, 2016)
Net income
Net income
N/A
Net income
N/A
Net income
($33m) (FY, 2017)
Net income
N/A
Net income
$399m (FY, 2016)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 30m (over 1 year ago)
Latest funding round
N/A
Latest funding round
$ 37m (about 6 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 158.6m
Total funding raised
$ 11.5m
Total funding raised
$ 37m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Tarveda Therapeutics
HQ
Watertown, US
Employees
33↑ 3% increase

Tarveda Therapeutics takes a novel approach to cancer treatment.

View company
CorMedix
HQ
Bedminster Township, US
Employees
14

CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.

View company
Pentec Health
HQ
Glen Mills, US
Employees
364

Pentec Health is a privately held specialty infusion services and healthcare technology company.

View company
Alexion Pharmaceuticals
HQ
New Haven, US
Employees
2,525↓ 19% decrease

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.

View company